Skip to Main Content

Author Details

Michael L Steinberg
University of California los angeles
1996
235
33
PMIDPaper TitleJournal TitlePublished Year
37871887Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial.Int J Radiat Oncol Biol Phys2024
37802226Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR.Int J Radiat Oncol Biol Phys2024
37516159Performance Analysis of a Radiation Oncology Educational Podcast.J Am Coll Radiol2024
35058580Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT.Prostate Cancer Prostatic Dis2023
37760626MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation.Cancers (Basel)2023
37647496Selecting the optimal radiation modality in prostate cancer.Clin Adv Hematol Oncol2023
37821097The Patient's perspective on radiation therapy for anal cancer: Evaluation of expectations and stigma.Cancer Rep (Hoboken)2023
37772467The patient's perspective on radiation for rectal cancer: Initial expectations versus actual experience.Cancer Med2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
37391235Proton Beam Therapy Training, Experience, and Assessment: Ready for Prime Time.Pract Radiat Oncol2023
37023987Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys2023
37152892Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States.Adv Radiat Oncol2023
37141981High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.Int J Radiat Oncol Biol Phys2023
36723856Multimodality Therapies for Localized Prostate Cancer.Curr Oncol Rep2023
36922079Radiation Oncologists and Therapeutic Radiopharmaceuticals: Will History Repeat Itself?Int J Radiat Oncol Biol Phys2023
36880064Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial.Clin Transl Radiat Oncol2023
36739178Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy.Clin Genitourin Cancer2023
36934894The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.Radiother Oncol2023
36532603Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19.Adv Radiat Oncol2023
36797449LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).BJU Int2023
36633877Magnetic Resonance Imaging-Guided vs Computed Tomography-Guided Stereotactic Body Radiotherapy for Prostate Cancer: The MIRAGE Randomized Clinical Trial.JAMA Oncol2023
36863416Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.Int J Radiat Oncol Biol Phys2023
36757690Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial.JAMA Oncol2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
36007724Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial.Int J Radiat Oncol Biol Phys2023
34107296Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial.Radiother Oncol2022
35350564Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel.Front Oncol2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35694034Characterizing Twitter Influencers in Radiation Oncology.Adv Radiat Oncol2022
35521072Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison.Adv Radiat Oncol2022
35912253Urethral Interfractional Geometric and Dosimetric Variations of Prostate Cancer Patients: A Study Using an Onboard MRI.Front Oncol2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
33602654Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.Eur Urol Oncol2022
34979212Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.Radiother Oncol2022
35033605Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types.Radiother Oncol2022
35205686A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes.Cancers (Basel)2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
34990726Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.Radiother Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
34866018Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.Clin Genitourin Cancer2022
34774650Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.Radiother Oncol2022
31411981Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.Eur Urol Oncol2021
33493615Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.Int J Radiat Oncol Biol Phys2021
33908045Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentation.Med Phys2021
33599771Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease.JAMA Netw Open2021
33898868Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System.Adv Radiat Oncol2021
33921062Automated Non-Coplanar VMAT for Dose Escalation in Recurrent Head and Neck Cancer Patients.Cancers (Basel)2021
33748547Weak Magnetic Fields Enhance the Efficacy of Radiation Therapy.Adv Radiat Oncol2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
  • 1 - 50 of 235

Recommended Authors

Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 4
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 7
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 31
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 1
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 23
Christine Massey
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 2
Danielle Rodin
Princess Margaret Cancer Centre, University of Toronto
Career Start Year 2009
Number of shared co-authors 10
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 8
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 8
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 21
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 6
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 17
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 37
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 7
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 4
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 16
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 11
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 9
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 51
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 11
Steve E Braunstein
University of California san francisco
Career Start Year 1998
Number of shared co-authors 7
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 14
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 8
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 24
William F Hartsell
Proton Therapy Center- Northwestern University
Career Start Year 1989
Number of shared co-authors 6
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Career Start Year 1987
Number of shared co-authors 20
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 31
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 18

Collaborators

Amar U Kishan
University of California los angeles
Co-authored papers 99
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 68
Christopher R King
University of California los angeles
Co-authored papers 57
Minsong Cao
University of California Los Angeles
Co-authored papers 54
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 48
Daniel A Low
University of California los angeles
Co-authored papers 41
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 34
Mitchell Kamrava
Cedars Sinai Medical Center
Co-authored papers 32
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 30
David Jeffrey Demanes
University of California los angeles
Co-authored papers 26
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 24
Fang-I Chu
David Geffen School of Medicine, University of California los angeles
Co-authored papers 24
Nzhde Agazaryan
University of California los angeles
Co-authored papers 23
Ting Martin Ma
University of Washington
Co-authored papers 20
Yingli Yang
Ruijin Hospital
Co-authored papers 19
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 17
Luca F Valle
University of California los angeles
Co-authored papers 17
Darlene Veruttipong
Stanford University
Co-authored papers 12
Rebecca Levin-Epstein
University of California los angeles
Co-authored papers 12
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 12
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 12
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 12
Kiri A Sandler
Oregon Health and Science University
Co-authored papers 12
Yu Gao
University of California los angeles
Co-authored papers 11
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 11
Dan Ruan
Zhongshan Hospital, Fudan University
Co-authored papers 11
Michael Xiang
University of California los angeles
Co-authored papers 10
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 10
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 10
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 10
Release 1.2